Phosphatidylcholine Supplementation in Infants

NCT01905605 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding not secured. IRB approval has been withdrawn as of January 2017.

Conditions

Schizophrenia
Diminished P50 Sensory Gating

Interventions

DRUG: phosphatidylcholine supplementation
DRUG: placebo

Sponsor

University of Colorado, Denver